CoStasis Stops Bleeding At Hard And Soft Tissue Sites - Cohesion PMA Study
This article was originally published in The Gray Sheet
Cohesion Technologies plans to file a premarket approval application this spring for its CoStasis surgical hemostat for treatment of bleeding in cardiovascular, hepatic, general and orthopedic surgery procedures, the firm announced Jan. 14.
You may also be interested in...
Tyco International's U.S. Surgical unit will market Cohesion Technologies' CoStasis liquid surgical hemostat. Shipments are expected to begin in early July.
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.